PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3050% below fair value
$23.54−0.26 (-1.09%)
Close on Nov 16, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for PROCEPT BioRobotics
PROCEPT BioRobotics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?